An investigation into anti-proliferative effects of microRNAs encoded by the miR-106a-363 cluster on human carcinoma cells and keratinocytes using microarray profiling of miRNA transcriptomes

Frontiers in Genetics

Volumn 5, Issue JUL, 2014, Pages

  Khuu, Cuong ^a   Jevnaker, Anne Marthe ^a   Bryne, Magne ^a   Osmundsen, Harald ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; BETA ACTIN; CYTOKERATIN 15; MICRORNA; MICRORNA 106A; MICRORNA 19A; MICRORNA 20B; MICRORNA 363; MICRORNA 92A; PROTEASOME; PROTEASOME SUBUNIT BETA TYPE 6; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CARCINOMA; CARCINOMA CELL LINE; CELL CLONE; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; COLON CANCER; CONTROLLED STUDY; DNA REPLICATION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KERATINOCYTE; MICROARRAY ANALYSIS; MOUTH SQUAMOUS CELL CARCINOMA; MRNA EXPRESSION ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; WESTERN BLOTTING;

EID: 84906248294     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00246     Document Type: Article

References (29)

1. Anaya-Ruiz, M., Bandala, C., and Perez-Santos, J.L. (2013). miR-485 Acts as a Tumor Suppressor by Inhibiting Cell Growth and Migration in Breast Carcinoma T47D Cells. Asian Pac J Cancer Prev 14, 3757-3760.
2. Avraham, R., and Yarden, Y. (2012). Regulation of signalling by microRNAs. Biochem Soc Trans 40, 26-30.
3. Bartel, D.P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
4. Dharap, A., and Vemuganti, R. (2010). Ischemic pre-conditioning alters cerebral microRNAs that are upstream to neuroprotective signaling pathways. Journal of Neurochemistry 113, 1685-1691.
5. Diermeier-Daucher, S., Clarke, S.T., Hill, D., Vollmann-Zwerenz, A., Bradford, J.A., and Brockhoff, G. (2009). Cell type specific applicability of 5-ethynyl-2'-deoxyuridine (EdU) for dynamic proliferation assessment in flow cytometry. Cytometry A 75, 535-546.
6. Fang, L., Deng, Z., Shatseva, T., Yang, J., Peng, C., Du, W.W., Yee, A.J., Ang, L.C., He, C., Shan, S.W., and Yang, B.B. (2011). MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-beta8. Oncogene 30, 806-821.
7. He, J.F., Luo, Y.M., Wan, X.H., and Jiang, D. (2011). Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J Biochem Mol Toxicol 25, 404-408.
8. He, L., Thomson, J.M., Hemann, M.T., Hernando-Monge, E., Mu, D., Goodson, S., Powers, S., Cordon-Cardo, C., Lowe, S.W., Hannon, G.J., and Hammond, S.M. (2005). A microRNA polycistron as a potential human oncogene. Nature 435, 828-833.
9. Hidaka, H., Seki, N., Yoshino, H., Yamasaki, T., Yamada, Y., Nohata, N., Fuse, M., Nakagawa, M., and Enokida, H. (2012). Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma. Oncotarget 3, 44-57.
10. Hochberg, Y., and Benjamini, Y. (1990). More powerful procedures for multiple significance testing. Stat Med 9, 811-818.
11. Jevnaker, A.M., Khuu, C., Kjole, E., Bryne, M., and Osmundsen, H. (2011). Expression of members of the miRNA17-92 cluster during development and in carcinogenesis. J Cell Physiol 226, 2257-2266.
12. Jevnaker, A.M., and Osmundsen, H. (2008). MicroRNA expression profiling of the developing murine molar tooth germ and the developing murine submandibular salivary gland. Arch Oral Biol 53, 629-645.
13. Jovanovic, M., and Hengartner, M.O. (2006). miRNAs and apoptosis: RNAs to die for. Oncogene 25, 6176-6187.
14. Kramer, A., Green, J., Pollard, J., Jr., and Tugendreich, S. (2014). Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523-530.
15. Landais, S., Landry, S., Legault, P., and Rassart, E. (2007). Oncogenic potential of the miR-106-363 cluster and its implication in human T-cell leukemia. Cancer Res 67, 5699-5707.
16. Lee, Y.S., and Dutta, A. (2009). MicroRNAs in Cancer. Annual Review of Pathology-Mechanisms of Disease 4, 199-227.
17. Liu, H., Yue, D., Chen, Y., Gao, S.J., and Huang, Y. (2010). Improving performance of mammalian microRNA target prediction. BMC Bioinformatics 11, 476.
18. Lu, Y., Thomson, J.M., Wong, H.Y., Hammond, S.M., and Hogan, B.L. (2007). Transgenic over-expression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol 310, 442-453.
19. Mendell, J.T. (2008). miRiad roles for the miR-17-92 cluster in development and disease. Cell 133, 217-222.
20. Murakami, Y., Tamori, A., Itami, S., Tanahashi, T., Toyoda, H., Tanaka, M., Wu, W., Brojigin, N., Kaneoka, Y., Maeda, A., Kumada, T., Kawada, N., Kubo, S., and Kuroda, M. (2013). The expression level of miR-18b in hepatocellular carcinoma is associated with the grade of malignancy and prognosis. BMC Cancer 13, 99.
21. Qin, X., Wang, X., Wang, Y., Tang, Z., Cui, Q., Xi, J., Li, Y.S., Chien, S., and Wang, N. (2010). MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc Natl Acad Sci U S A 107, 3240-3244.
22. Rozen, S., and Skaletsky, H. (2000). Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132, 365-386.
23. Sun, Q., Zhang, J., Cao, W., Wang, X., Xu, Q., Yan, M., Wu, X., and Chen, W. (2013). Dysregulated miR-363 affects head and neck cancer invasion and metastasis by targeting podoplanin. Int J Biochem Cell Biol 45, 513-520.
24. Van Der Auwera, I., Limame, R., Van Dam, P., Vermeulen, P.B., Dirix, L.Y., and Van Laere, S.J. (2010). Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype. Br J Cancer 103, 532-541.
25. Van Iterson, M., Bervoets, S., De Meijer, E.J., Buermans, H.P., T Hoen, P.A., Menezes, R.X., and Boer, J.M. (2013). Integrated analysis of microRNA and mRNA expression: adding biological significance to microRNA target predictions. Nucleic Acids Res.
26. Ventura, A., Young, A.G., Winslow, M.M., Lintault, L., Meissner, A., Erkeland, S.J., Newman, J., Bronson, R.T., Crowley, D., Stone, J.R., Jaenisch, R., Sharp, P.A., and Jacks, T. (2008). Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell 132, 875-886.
27. Yamada, Y., Hidaka, H., Seki, N., Yoshino, H., Yamasaki, T., Itesako, T., Nakagawa, M., and Enokida, H. (2013). Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci 104, 304-312.
28. Yang, G., Zhang, R., Chen, X., Mu, Y., Ai, J., Shi, C., Liu, Y., Shi, C., Sun, L., Rainov, N.G., Li, H., Yang, B., and Zhao, S. (2011). MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. J Mol Med (Berl) 89, 1037-1050.
29. Zhang, Y., Zhang, R., and Su, B. (2009). Diversity and evolution of MicroRNA gene clusters. Sci China C Life Sci 52, 261-266.